JP7802802B2 - リスクベースのインスリン送達変換のためのシステム及び方法 - Google Patents

リスクベースのインスリン送達変換のためのシステム及び方法

Info

Publication number
JP7802802B2
JP7802802B2 JP2023539889A JP2023539889A JP7802802B2 JP 7802802 B2 JP7802802 B2 JP 7802802B2 JP 2023539889 A JP2023539889 A JP 2023539889A JP 2023539889 A JP2023539889 A JP 2023539889A JP 7802802 B2 JP7802802 B2 JP 7802802B2
Authority
JP
Japan
Prior art keywords
insulin
risk
data
rate
insulin delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023539889A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024504276A5 (enExample
JP2024504276A (ja
Inventor
スティーヴン・ディー・パテク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dexcom Inc
Original Assignee
Dexcom Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexcom Inc filed Critical Dexcom Inc
Publication of JP2024504276A publication Critical patent/JP2024504276A/ja
Publication of JP2024504276A5 publication Critical patent/JP2024504276A5/ja
Application granted granted Critical
Publication of JP7802802B2 publication Critical patent/JP7802802B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4836—Diagnosis combined with treatment in closed-loop systems or methods
    • A61B5/4839—Diagnosis combined with treatment in closed-loop systems or methods combined with drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7271—Specific aspects of physiological measurement analysis
    • A61B5/7275—Determining trends in physiological measurement data; Predicting development of a medical condition based on physiological measurements, e.g. determining a risk factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00—Computing arrangements based on biological models
    • G06N3/02—Neural networks
    • G06N3/04—Architecture, e.g. interconnection topology
    • G06N3/045—Combinations of networks
    • G06N3/0455—Auto-encoder networks; Encoder-decoder networks
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
    • H04N19/00—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals
    • H04N19/70—Methods or arrangements for coding, decoding, compressing or decompressing digital video signals characterised by syntax aspects related to video coding, e.g. related to compression standards
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
    • H04N21/00—Selective content distribution, e.g. interactive television or video on demand [VOD]
    • H04N21/40—Client devices specifically adapted for the reception of or interaction with content, e.g. set-top-box [STB]; Operations thereof
    • H04N21/43—Processing of content or additional data, e.g. demultiplexing additional data from a digital video stream; Elementary client operations, e.g. monitoring of home network or synchronising decoder's clock; Client middleware
    • H04N21/435—Processing of additional data, e.g. decrypting of additional data, reconstructing software from modules extracted from the transport stream
    • H—ELECTRICITY
    • H04—ELECTRIC COMMUNICATION TECHNIQUE
    • H04N—PICTORIAL COMMUNICATION, e.g. TELEVISION
    • H04N21/00—Selective content distribution, e.g. interactive television or video on demand [VOD]
    • H04N21/40—Client devices specifically adapted for the reception of or interaction with content, e.g. set-top-box [STB]; Operations thereof
    • H04N21/43—Processing of content or additional data, e.g. demultiplexing additional data from a digital video stream; Elementary client operations, e.g. monitoring of home network or synchronising decoder's clock; Client middleware
    • H04N21/44—Processing of video elementary streams, e.g. splicing a video clip retrieved from local storage with an incoming video stream or rendering scenes according to encoded video stream scene graphs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/20—Blood composition characteristics
    • A61M2230/201—Glucose concentration

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Data Mining & Analysis (AREA)
  • Signal Processing (AREA)
  • Theoretical Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Artificial Intelligence (AREA)
  • Multimedia (AREA)
  • Surgery (AREA)
  • Databases & Information Systems (AREA)
  • Mathematical Physics (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Computing Systems (AREA)
  • General Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Computational Linguistics (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Diabetes (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Physiology (AREA)
  • Psychiatry (AREA)
JP2023539889A 2021-02-03 2022-02-03 リスクベースのインスリン送達変換のためのシステム及び方法 Active JP7802802B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163145224P 2021-02-03 2021-02-03
US63/145,224 2021-02-03
PCT/US2022/015065 WO2022169942A1 (en) 2021-02-03 2022-02-03 Systems and methods for risk based insulin delivery conversion

Publications (3)

Publication Number Publication Date
JP2024504276A JP2024504276A (ja) 2024-01-31
JP2024504276A5 JP2024504276A5 (enExample) 2025-02-10
JP7802802B2 true JP7802802B2 (ja) 2026-01-20

Family

ID=80446135

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023539889A Active JP7802802B2 (ja) 2021-02-03 2022-02-03 リスクベースのインスリン送達変換のためのシステム及び方法

Country Status (7)

Country Link
US (4) US20220246264A1 (enExample)
EP (1) EP4288968A1 (enExample)
JP (1) JP7802802B2 (enExample)
CN (1) CN116762136A (enExample)
AU (1) AU2022215576A1 (enExample)
CA (1) CA3210305A1 (enExample)
WO (1) WO2022169942A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240075208A1 (en) * 2022-09-01 2024-03-07 Insulet Corporation Method for detecting occlusions in a fluid path using blood glucose readings
US20240249810A1 (en) * 2023-01-19 2024-07-25 Dexcom, Inc. Systems and methods for risk based insulin delivery conversion
CN117542476A (zh) * 2023-10-08 2024-02-09 上海市闵行区中西医结合医院(上海市闵行区结核病防治院) 一种基于自学习的胰岛素注射剂量监管方法及系统
CN117612692B (zh) * 2024-01-19 2024-04-05 太原理工大学 一种基于连续血糖监测的胰岛素泵故障诊断系统及方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012527981A (ja) 2009-05-29 2012-11-12 ユニバーシティ オブ バージニア パテント ファウンデーション 糖尿病の開ループおよび閉ループ制御のためのシステムコーディネータおよびモジュールアーキテクチャ
JP2020515925A (ja) 2016-11-29 2020-05-28 ノボ・ノルデイスク・エー／エス 基礎速度滴定のためのスターターキット
US20200205742A1 (en) 2018-12-28 2020-07-02 Dexcom, Inc. Evaluation and visualization of glycemic dysfunction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016133879A1 (en) 2015-02-16 2016-08-25 University Of Virginia Patent Foundation Method, system and computer readable medium for assessing actionable glycemic risk
US11311665B2 (en) 2015-06-09 2022-04-26 University Of Virginia Patent Foundation Insulin monitoring and delivery system and method for CGM based fault detection and mitigation via metabolic state tracking

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012527981A (ja) 2009-05-29 2012-11-12 ユニバーシティ オブ バージニア パテント ファウンデーション 糖尿病の開ループおよび閉ループ制御のためのシステムコーディネータおよびモジュールアーキテクチャ
JP2020515925A (ja) 2016-11-29 2020-05-28 ノボ・ノルデイスク・エー／エス 基礎速度滴定のためのスターターキット
US20200205742A1 (en) 2018-12-28 2020-07-02 Dexcom, Inc. Evaluation and visualization of glycemic dysfunction

Also Published As

Publication number Publication date
EP4288968A1 (en) 2023-12-13
US20220246265A1 (en) 2022-08-04
JP2024504276A (ja) 2024-01-31
AU2022215576A1 (en) 2023-09-07
CA3210305A1 (en) 2022-08-11
CN116762136A (zh) 2023-09-15
US20220240848A1 (en) 2022-08-04
US20230329633A1 (en) 2023-10-19
WO2022169942A1 (en) 2022-08-11
US20220246264A1 (en) 2022-08-04

Similar Documents

Publication Publication Date Title
US11744947B2 (en) Glucose control system with control parameter modification
CA2612714C (en) Fully automated control system for type 1 diabetes
US20230329633A1 (en) Systems and Methods for Risk Based Insulin Delivery Conversion
US11957876B2 (en) Glucose control system with automated backup therapy protocol generation
JP7607291B2 (ja) 血中グルコース制御システム
Kovatchev et al. Control to range for diabetes: functionality and modular architecture
US20200015760A1 (en) Method to determine individualized insulin sensitivity and optimal insulin dose by linear regression, and related systems
EP3902469B1 (en) Evaluation and visualization of glycemic dysfunction
WO2015056259A1 (en) System and method for improved artificial pancreas management
EP2166946A1 (en) Lqg artificial pancreas control system and related method
CN114173644B (zh) 动态等效体载估计器
JP7785832B2 (ja) 被験者のグルコース変化を判定するための方法
US20240249810A1 (en) Systems and methods for risk based insulin delivery conversion
WO2020127936A1 (en) Method for estimating glycemia and/or controlling an insulin injection device
US20220193338A1 (en) Bolus advisor with correction boluses based on risk, carb-free bolus recommender, and meal acknowledgement
JP7785762B2 (ja) リスクに基づく補正ボーラスを有するボーラスアドバイザ、炭水化物を含まないボーラス推奨器、及び食事承認
EP4205131A1 (en) Method and system for determining optimal and recommended therapy parameters for diabetic subject
JP2025515419A (ja) 基礎インスリン用量を滴定するためのシステム及び方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250131

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250131

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20251128

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251209

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260107

R150 Certificate of patent or registration of utility model

Ref document number: 7802802

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150